vs
Side-by-side financial comparison of BK Technologies Corp (BKTI) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
BK Technologies Corp is the larger business by last-quarter revenue ($21.5M vs $18.3M, roughly 1.2× ROCKWELL MEDICAL, INC.). BK Technologies Corp runs the higher net margin — 19.7% vs -3.0%, a 22.7% gap on every dollar of revenue. On growth, BK Technologies Corp posted the faster year-over-year revenue change (20.0% vs -25.6%). BK Technologies Corp produced more free cash flow last quarter ($2.8M vs $2.2M). Over the past eight quarters, ROCKWELL MEDICAL, INC.'s revenue compounded faster (-10.1% CAGR vs -21.6%).
BK Technologies Corp designs, manufactures and sells analog and digital two-way radio communications equipment and related accessories. It serves public safety departments, first responders, government agencies and commercial clients primarily across North America, focusing on reliable, mission-critical communication solutions.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
BKTI vs RMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.5M | $18.3M |
| Net Profit | $4.2M | $-554.0K |
| Gross Margin | 50.5% | 21.1% |
| Operating Margin | 19.7% | -2.2% |
| Net Margin | 19.7% | -3.0% |
| Revenue YoY | 20.0% | -25.6% |
| Net Profit YoY | 15.6% | 26.7% |
| EPS (diluted) | $1.06 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $21.5M | $18.3M | ||
| Q3 25 | $24.4M | $15.9M | ||
| Q2 25 | $21.2M | $16.1M | ||
| Q1 25 | $19.1M | $18.9M | ||
| Q4 24 | $17.9M | $24.7M | ||
| Q3 24 | $20.2M | $28.3M | ||
| Q2 24 | $20.3M | $25.8M | ||
| Q1 24 | — | $22.7M |
| Q4 25 | $4.2M | $-554.0K | ||
| Q3 25 | $3.4M | $-1.8M | ||
| Q2 25 | $3.7M | $-1.5M | ||
| Q1 25 | $2.1M | $-1.5M | ||
| Q4 24 | $3.7M | $-756.0K | ||
| Q3 24 | $2.4M | $1.7M | ||
| Q2 24 | $1.7M | $343.0K | ||
| Q1 24 | — | $-1.7M |
| Q4 25 | 50.5% | 21.1% | ||
| Q3 25 | 49.9% | 14.3% | ||
| Q2 25 | 47.4% | 15.6% | ||
| Q1 25 | 47.0% | 16.1% | ||
| Q4 24 | 41.2% | 14.7% | ||
| Q3 24 | 38.8% | 22.0% | ||
| Q2 24 | 37.3% | 17.6% | ||
| Q1 24 | — | 13.5% |
| Q4 25 | 19.7% | -2.2% | ||
| Q3 25 | 19.8% | -9.9% | ||
| Q2 25 | 18.9% | -8.4% | ||
| Q1 25 | 15.3% | -7.2% | ||
| Q4 24 | 12.3% | -2.1% | ||
| Q3 24 | 12.9% | 6.8% | ||
| Q2 24 | 10.0% | 2.0% | ||
| Q1 24 | — | -5.8% |
| Q4 25 | 19.7% | -3.0% | ||
| Q3 25 | 14.1% | -11.0% | ||
| Q2 25 | 17.7% | -9.3% | ||
| Q1 25 | 11.2% | -8.0% | ||
| Q4 24 | 20.4% | -3.1% | ||
| Q3 24 | 11.7% | 5.9% | ||
| Q2 24 | 8.2% | 1.3% | ||
| Q1 24 | — | -7.6% |
| Q4 25 | $1.06 | $-0.01 | ||
| Q3 25 | $0.87 | $-0.05 | ||
| Q2 25 | $0.96 | $-0.05 | ||
| Q1 25 | $0.55 | $-0.04 | ||
| Q4 24 | $0.96 | $-0.02 | ||
| Q3 24 | $0.63 | $0.04 | ||
| Q2 24 | $0.47 | $0.01 | ||
| Q1 24 | — | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $22.8M | $10.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $44.7M | $37.0M |
| Total Assets | $63.8M | $57.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $22.8M | $10.7M | ||
| Q3 25 | $21.5M | $13.6M | ||
| Q2 25 | $11.9M | $12.5M | ||
| Q1 25 | $8.9M | $11.4M | ||
| Q4 24 | $7.1M | $15.7M | ||
| Q3 24 | $4.2M | $12.3M | ||
| Q2 24 | $3.0M | $11.9M | ||
| Q1 24 | — | $6.6M |
| Q4 25 | $44.7M | $37.0M | ||
| Q3 25 | $41.0M | $37.0M | ||
| Q2 25 | $36.8M | $30.4M | ||
| Q1 25 | $32.4M | $31.5M | ||
| Q4 24 | $29.8M | $32.6M | ||
| Q3 24 | $26.0M | $29.1M | ||
| Q2 24 | $23.4M | $23.5M | ||
| Q1 24 | — | $20.6M |
| Q4 25 | $63.8M | $57.1M | ||
| Q3 25 | $66.9M | $57.5M | ||
| Q2 25 | $60.4M | $52.6M | ||
| Q1 25 | $56.1M | $54.0M | ||
| Q4 24 | $51.5M | $59.2M | ||
| Q3 24 | $46.4M | $57.1M | ||
| Q2 24 | $48.9M | $53.0M | ||
| Q1 24 | — | $50.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.0M | $2.3M |
| Free Cash FlowOCF − Capex | $2.8M | $2.2M |
| FCF MarginFCF / Revenue | 13.2% | 12.0% |
| Capex IntensityCapex / Revenue | 0.7% | 0.5% |
| Cash ConversionOCF / Net Profit | 0.71× | — |
| TTM Free Cash FlowTrailing 4 quarters | $18.4M | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.0M | $2.3M | ||
| Q3 25 | $10.4M | $-1.3M | ||
| Q2 25 | $3.9M | $1.8M | ||
| Q1 25 | $2.1M | $-3.5M | ||
| Q4 24 | $3.8M | $865.0K | ||
| Q3 24 | $5.7M | $4.3M | ||
| Q2 24 | $4.1M | $1.4M | ||
| Q1 24 | — | $-2.4M |
| Q4 25 | $2.8M | $2.2M | ||
| Q3 25 | $10.1M | $-1.5M | ||
| Q2 25 | $3.7M | $1.7M | ||
| Q1 25 | $1.8M | $-3.5M | ||
| Q4 24 | $3.4M | $470.0K | ||
| Q3 24 | $5.2M | $4.1M | ||
| Q2 24 | $3.9M | $1.2M | ||
| Q1 24 | — | $-2.5M |
| Q4 25 | 13.2% | 12.0% | ||
| Q3 25 | 41.3% | -9.6% | ||
| Q2 25 | 17.3% | 10.5% | ||
| Q1 25 | 9.6% | -18.8% | ||
| Q4 24 | 19.2% | 1.9% | ||
| Q3 24 | 25.8% | 14.4% | ||
| Q2 24 | 19.2% | 4.5% | ||
| Q1 24 | — | -11.1% |
| Q4 25 | 0.7% | 0.5% | ||
| Q3 25 | 1.5% | 1.4% | ||
| Q2 25 | 1.2% | 1.0% | ||
| Q1 25 | 1.4% | 0.3% | ||
| Q4 24 | 2.0% | 1.6% | ||
| Q3 24 | 2.2% | 0.7% | ||
| Q2 24 | 1.0% | 1.1% | ||
| Q1 24 | — | 0.6% |
| Q4 25 | 0.71× | — | ||
| Q3 25 | 3.04× | — | ||
| Q2 25 | 1.04× | — | ||
| Q1 25 | 0.98× | — | ||
| Q4 24 | 1.04× | — | ||
| Q3 24 | 2.40× | 2.57× | ||
| Q2 24 | 2.46× | 4.20× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BKTI
Segment breakdown not available.
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
